SEARCH RESULTS FOR: "Tag: AMGN"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022(2)
2021(1)
2020(6)
2019(6)
2018(1)
2017(13)
2016(8)
2015(8)
CATEGORIES
Analyst Downgrades(3)
Analyst Update(5)
Analyst Upgrades(2)
Best and Worst Stocks(1)
Buzz Stocks(9)
By the Numbers(1)
Expectational Analysis(1)
General(2)
Indexes and ETFs(1)
Indicator of the Week(2)
Intraday Option Activity(4)
Market Recap(2)
Midday Market Check(2)
Opening View(3)
Quantitative Analysis(4)
Stock Market News(2)
Stocks On the Move(8)

5/31/2022 3:07 PM
Blue-chip name Amgen, Inc. (NASDAQ:AMGN) earlier reported its olpasiran therapy helped reduce cholesterol levels in patients with atherosclerotic cardiovascular disease (ASCVD), according to topline ...
3/3/2022 3:04 PM
Amgen Inc. (NASDAQ:AMGN) is an American multinational biopharmaceutical company. AMGN's goal is to provide a healthcare business based on recombinant DNA technology by discovering, developing, manuf...
8/4/2021 11:19 AM
The shares of Amgen, Inc. (NASDAQ:AMGN) are slipping this morning, last seen off 1% at $241.60, after the firm lowered its full-year net earnings guidance, noting that the pandemic has kept a lid on ...
10/28/2020 8:12 AM
We saw investor sentiment sour throughout the day yesterday, with both the Dow and the S&P 500 dipping into the red by Tuesday's closing bell. New records were set in new COVID-19 cases across the U.S...
10/12/2020 2:14 PM
The shares of blue chip Amgen, Inc. (NASDAQ:AMGN) are up 1.8% at $241.07 this afternoon. However, the biopharmaceutical stock has traded sideways the past few months after hitting an all-time-high of ...
 
Special Offers from Schaeffer's Trading Partners